As wearable devices evolve from fitness companions into full-scale health platforms, Whoop is betting users will pay for instant medical guidance powered by continuous biometric monitoring, AI-driven coaching, and direct access to licensed clinicians inside the same app that once only tracked sleep, recovery, and workouts.
Fitness wearable maker Whoop has announced it will roll out in-app access to on-demand licensed clinicians for users in the United States, expanding its push into personalized digital health services.
The new feature is part of a broader set of health and artificial intelligence-driven tools launching globally that aim to connect users’ continuous biometric data with medical guidance in real time.
Many of the new features will be included in the cost of membership, though live video consultations for U.S. users will carry an additional fee. Pricing and launch details will be disclosed ahead of the summer rollout, the company said.
“Whoop is a membership, and we take that seriously,” Ed Baker, chief product officer at Whoop, said in a statement. “We’re always asking how we can deliver more value to our members, and these upcoming features are some of the most meaningful we’ve ever built.”
The company, which says it has more than 2.5 million users worldwide, raised $575 million in a funding round in March that valued it at $10.1 billion.
Whoop said medical consultations will begin with a review of data collected by the wearable device and, where available, blood work and medical history.
A company spokesperson said the video consultation service is intended to complement existing medical care rather than replace primary care physicians or emergency services. The spokesperson declined to say whether the platform would provide prescriptions.
“As our data and coaching insights have become more advanced and personalized, the next step is giving members access to a comprehensive understanding of their overall health,” Whoop Chief Executive Will Ahmed told CNBC.
The update also includes a partnership with HealthEx, allowing users to store diagnoses, medications and procedures within the Whoop app and receive AI-powered coaching and proactive reminders.
The expansion comes less than a year after the U.S. Food and Drug Administration sent Whoop a warning letter over its Blood Pressure Insights feature, saying the company was marketing an unauthorized medical device intended to diagnose, cure, treat or prevent disease.
However, new FDA guidance issued in January permits optical blood pressure measurements in wellness devices as long as companies avoid making “medical-grade” diagnostic claims.
Stay ahead of the stories shaping our world. Subscribe to Impact Newswire for timely, curated insights on global tech, business, and innovation all in one place.
Dive deeper into the future with the Cause Effect 4.0 Podcast, where we explore the ideas, trends, and technologies driving the global AI conversation.
Got a story to share? Pitch it to us at info@impactnews-wire.com and reach the right audience worldwide
Faustine Ngila is the AI Editor at Impact Newswire, based in Nairobi, Kenya. He is an award-winning journalist specializing in artificial intelligence, blockchain, and emerging technologies.
He previously worked as a global technology reporter at Quartz in New York and Digital Frontier in London, where he covered innovation, startups, and the global digital economy.
With years of experience reporting on cutting-edge technologies, Faustine focuses on AI developments, industry trends, and the impact of technology on society.
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.
